Nanoparticles targeted to fibroblast activation protein outperform PSMA for MRI delineation of primary prostate tumours
N. Dmochowska, V. Milanova, R. Mukkamala, K. K. Chow, N. T. Pham, M. Srinivasarao, L. M. Ebert, T. Stait-Gardner, H. Le, A. Shetty, M. Nelson, P. S. Low, B. Thierry
This study compares FAP-targeted MRI with PSMA-targeted MRI for delineating prostate tumors in mice, finding FAP provides better contrast enhancement.
bioRxiv · Jun 10, 2022 · PreprintBioengineering